FDA recall record

SUN PHARMACEUTICAL INDUSTRIES Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg recall — FDA D-1445-2020

Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

Class IIIclassification
D-1445-2020official record ID
Aug 5, 2020report date

Recall record at a glance

Official recordD-1445-2020
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmSUN PHARMACEUTICAL INDUSTRIES Inc.
Report dateAug 5, 2020
Recall initiation dateJul 6, 2020
Quantity3516 bottles
LocationPrinceton, NJ, United States

Official product description

Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86

Why the product was recalled

Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

Distribution information

Nationwide USA

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugApr 22, 2026

FLUOCINONIDE recall — FDA D-0476-2026

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Class IIFDA: OngoingSUN PHARMACEUTICAL INDUSTRIES INC